FDX1 as a novel biomarker and treatment target for stomach adenocarcinoma

Figure 6 Gene Set Enrichment Analysis of the dataset The Cancer Genome Atlas-stomach adenocarcinoma. A: Mountain plot of Gene Set Enrichment Analysis (GSEA) results for the dataset The Cancer Genome Atlas (TCGA)-stomach adenocarcinoma (STAD) for gastric cancer (STAD); B: GSEA of all genes in the dataset TCGA-STAD in high and low risk subgroups (subgroup: High and subgroup: Low) vs HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION; C: Visualization of GSEA outcomes of all genes in the dataset TCGA-STAD in high and low risk groupings (grouping: High and grouping: Low) vs HALLMARK_MYOGENESIS; D: Visualization of GSEA outcomes of all genes in the dataset TCGA-STAD in high and low risk groupings (grouping: High and grouping: Low) vs visualization of GSEA results for HALLMARK_COAGULATION; E: Visualization of GSEA results for all genes in the dataset TCGA-STAD in high and low risk groupings (grouping: High and grouping: Low) vs HALLMARK_APICAL_JUNCTION. FDR: False discovery rate.